Clinical Trials

Sotrastaurin in psoriasis

A 2-week multiple ascending dose, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of oral AEB071, a protein kinase C inhibitor, in moderate to severe psoriasis patients

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here